U.S. Pharmacogenomics Market Growth 2025 Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a pati ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

Highly valued economically, ecologically and culturally, the white oak (Quercus alba) is a keystone forest species and is one ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 19, 2025 /PRNewswire/ -- USA News Group News Commentary - Amid the excitement surrounding ...

NeoGenomics reported mixed results for the fourth quarter. While it beat on earnings (after adjustments), it missed on ...

A cohort of academic theme leads has been appointed to strengthen transatlantic ties through new convergence science and ...

GeneDx excels in comprehensive genome and exome testing using a vast genetic database linking 400+ diseases. See why I think ...

HKGI Partners with Global Leaders to Chart a Course for Healthcare Transformation HONG KONG, /PRNewswire/ -- Genomic medicine has been gaining global prominence for its vast potential to ...

What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 21.5% in the afternoon session ...

Whole Genome Amplification MarketThe global whole genome amplification (WGA) market is on track for substantial growth, with projections indicating that it will exceed USD 6.5 million by 2034. In 2024 ...

Usually, ‘What happens in Vegas, stays in Vegas’, is the prevailing moto of Sin City, but that is certainly not the case for ...